دورية أكاديمية
Inferior vena cava filters: Concept review and summary of current guidelines.
| العنوان: | Inferior vena cava filters: Concept review and summary of current guidelines. |
|---|---|
| المؤلفون: | Visconti L; Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa and Pulmonary Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Pulmonary Unit, Ospedale 'Sacro Cuore di Gesù' Gallipoli, Azienda Sanitaria Locale Lecce, Italy., Celi A; Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa and Pulmonary Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Pulmonary Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. Electronic address: alessandro.celi@unipi.it., Carrozzi L; Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa and Pulmonary Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Pulmonary Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Tinelli C; Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa and Pulmonary Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Crocetti L; Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa and Interventional Radiology Unit, University of Pisa, Pisa, Italy., Daviddi F; Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa and Interventional Radiology Unit, University of Pisa, Pisa, Italy., De Caterina R; Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa and Cardiology Unit, Cardio-Thoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Madonna R; Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa and Cardiology Unit, Cardio-Thoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Pancani R; Pulmonary Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. |
| المصدر: | Vascular pharmacology [Vascul Pharmacol] 2024 Jun; Vol. 155, pp. 107375. Date of Electronic Publication: 2024 Apr 24. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3649 (Electronic) Linking ISSN: 15371891 NLM ISO Abbreviation: Vascul Pharmacol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, NY : Elsevier Science, c2002- |
| مواضيع طبية MeSH: | Vena Cava Filters*/adverse effects , Pulmonary Embolism*/prevention & control , Practice Guidelines as Topic* , Anticoagulants*/therapeutic use , Anticoagulants*/adverse effects , Anticoagulants*/administration & dosage , Prosthesis Design*, Humans ; Risk Factors ; Treatment Outcome ; Hemorrhage/chemically induced ; Hemorrhage/prevention & control ; Risk Assessment ; Prosthesis Implantation/adverse effects ; Prosthesis Implantation/instrumentation ; Vena Cava, Inferior |
| مستخلص: | Anticoagulation is the first-line approach in the prevention and treatment of pulmonary embolism. In some instances, however, anticoagulation fails, or cannot be administered due to a high risk of bleeding. Inferior vena cava filters are metal alloy devices that mechanically trap emboli from the deep leg veins halting their transit to the pulmonary circulation, thus providing a mechanical alternative to anticoagulation in such conditions. The Greenfield filter was developed in 1973 and was later perfected to a model that could be inserted percutaneously. Since then, this model has been the reference standard. The current class I indication for this device includes absolute contraindication to anticoagulants in the presence of acute thromboembolism and recurrent thromboembolism despite adequate therapy. Additional indications have been more recently proposed, due to the development of removable filters and of progressively less invasive techniques. Although the use of inferior vena cava filters has solid theoretical advantages, clinical efficacy and adverse event profile are still unclear. This review analyzes the most important studies related to such devices, open issues, and current guideline recommendations. Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Grant FOR READINGS/SPEECHES AT CONFERENCES: Chiesi, GSK, Firma, Guidotti, Sanofi, Astrazeneca. Project with drug development: Chiesi and Astrazeneca. Project without drug development: GSK. (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Anticoagulants; Inferior vena cava filters; Interventional radiology; Pulmonary embolism |
| المشرفين على المادة: | 0 (Anticoagulants) |
| تواريخ الأحداث: | Date Created: 20240425 Date Completed: 20240620 Latest Revision: 20240620 |
| رمز التحديث: | 20240621 |
| DOI: | 10.1016/j.vph.2024.107375 |
| PMID: | 38663572 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1879-3649 |
|---|---|
| DOI: | 10.1016/j.vph.2024.107375 |